No account needed. By playing, you confirm you're 13 or older and agree to the Terms of use.
No owners yet
Category: Empty
- 0 owners
- 0 copies
- 0 pulls
- Wishlisted
- 0
- In 0 albums
- On 0 showcases
- Market listings
- 0
Not sold on the market yet.
Readers' pathsAug 2026 – Oct 2026
Readers go next to
Share of the 734 clicks on its links
Glovadalen
D1 receptor positive allosteric modulator under development for Parkinson's disease.
14%
Dopamine agonist
Compound that activates dopamine receptors.
13%
Razpipadon
Chemical compound.
11%
PF-06412562
Pharmaceutical compound.
7.2%
Rotigotine
Dopamine agonist medication.
5.6%
Mevidalen
Chemical compound.
4.8%
Parkinson's disease
Progressive neurodegenerative disease.
4.4%
Dopamine receptor D1
Protein-coding gene in humans.
3.5%
Clinical trial
Phase of clinical research in medicine.
2%
CYP3A4
Enzyme that metabolizes substances by oxidation.
1.8%
Readers come from
Share of the 242 readers arriving from another article